PE20030923A1 - Forma polimorfica cristalina de clorhidrato de irinotecan - Google Patents
Forma polimorfica cristalina de clorhidrato de irinotecanInfo
- Publication number
- PE20030923A1 PE20030923A1 PE2003000196A PE2003000196A PE20030923A1 PE 20030923 A1 PE20030923 A1 PE 20030923A1 PE 2003000196 A PE2003000196 A PE 2003000196A PE 2003000196 A PE2003000196 A PE 2003000196A PE 20030923 A1 PE20030923 A1 PE 20030923A1
- Authority
- PE
- Peru
- Prior art keywords
- refers
- polymorphic form
- irinotecan hydrochloride
- irinotecan
- crystalline polymorphic
- Prior art date
Links
- 229960000779 irinotecan hydrochloride Drugs 0.000 title abstract 2
- GURKHSYORGJETM-WAQYZQTGSA-N irinotecan hydrochloride (anhydrous) Chemical compound Cl.C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 GURKHSYORGJETM-WAQYZQTGSA-N 0.000 title abstract 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 abstract 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 238000002441 X-ray diffraction Methods 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000002329 infrared spectrum Methods 0.000 abstract 1
- 229960004768 irinotecan Drugs 0.000 abstract 1
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA FORMA POLIMORFICA DE CLORHIDRATO DE IRINOTECAN CRISTALINO DE FORMULA I CARACTERIZADO POR UN PATRON DE DIFRACCION DE RAYOS X DE POLVO QUE COMPRENDE VALORES DE ANGULO 2 THETA 9,15; 10,00; 11,80; 12,20; 13,00; 13,40. PRESENTA ADEMAS UN ESPECTRO INFRARROJO QUE CONTIENE PICOS EN 1757, 1712 Y 1667 cm-1. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA PREPARAR EL POLIMORFO QUE CONSISTE EN AGITAR DURANTE UN TIEPMO DE 2 A 48 HORAS UNA SUSPENSION ACUOSA DEL CLORHIDRATO DE IRINOTECAN COMO FORMA b O COMO AMORFO EN ACETONITRILO O EN ACETONA. SE REFIERE ADEMAS A UNA COMPOSICION FARMACEUTICA UTIL PARA EL TRATAMIENTO DE CANCER
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36068402P | 2002-03-01 | 2002-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030923A1 true PE20030923A1 (es) | 2003-10-29 |
Family
ID=27789001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000196A PE20030923A1 (es) | 2002-03-01 | 2003-02-28 | Forma polimorfica cristalina de clorhidrato de irinotecan |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1487840B1 (es) |
| JP (1) | JP2005525367A (es) |
| KR (1) | KR20040091083A (es) |
| CN (1) | CN1276923C (es) |
| AR (1) | AR038618A1 (es) |
| AT (1) | ATE364610T1 (es) |
| AU (1) | AU2003215594A1 (es) |
| BR (1) | BR0308133A (es) |
| CA (1) | CA2477926A1 (es) |
| DE (1) | DE60314378T2 (es) |
| DK (1) | DK1487840T3 (es) |
| ES (1) | ES2287495T3 (es) |
| IL (1) | IL163820A0 (es) |
| MX (1) | MXPA04008484A (es) |
| NO (1) | NO20044138L (es) |
| NZ (1) | NZ534999A (es) |
| PE (1) | PE20030923A1 (es) |
| PL (1) | PL372318A1 (es) |
| PT (1) | PT1487840E (es) |
| RU (1) | RU2300535C2 (es) |
| TW (1) | TWI270374B (es) |
| WO (1) | WO2003074527A1 (es) |
| ZA (1) | ZA200406927B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101095382B1 (ko) * | 2003-02-25 | 2011-12-16 | 가부시키가이샤 야쿠르트 혼샤 | 이리노테칸 염산염의 결정다형의 제조방법 |
| ES2245891B1 (es) * | 2004-07-09 | 2006-11-16 | Clinmet S.L. | "metodo para la obtencion de un excipiente universal para la administracion oral de principios activos farmaceuticos y composiciones de excipientes resultantes del metodo". |
| EP1828196B1 (en) | 2004-12-21 | 2012-10-17 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Stereoselective process and crystalline forms of a camptothecin |
| ES2333462T3 (es) | 2005-02-07 | 2010-02-22 | Fermion Oy | Procedimiento para la preparacion de 7-etil-10-hidroxi camptotecina. |
| JP5133703B2 (ja) | 2005-02-08 | 2013-01-30 | フェルミオン オサケ ユキチュア | ［１，４’］ビピペリジニル−１’−カルボニルクロリドまたはその塩酸塩の製造方法 |
| US7767813B2 (en) | 2005-02-08 | 2010-08-03 | Fermion Oy | Preparation method |
| EP2082741A1 (en) * | 2005-09-20 | 2009-07-29 | Scinopharm Singapore Pte, Ltd. | Novel crystal form of irinotecan hydrochloride |
| CN101318964B (zh) * | 2007-06-07 | 2010-12-15 | 上海迪赛诺医药发展有限公司 | 盐酸伊立替康新晶型及其制备方法 |
| FR2918279B1 (fr) * | 2007-07-05 | 2010-10-22 | Aventis Pharma Sa | Combinaisons antitumorales contenant un agent inhibiteur de vegf et de l'irinotecan |
| IT1391757B1 (it) * | 2008-11-11 | 2012-01-27 | Antibioticos Spa | Irinotecan cloridrato cristallino e metodi per la sua preparazione |
| CN101659667B (zh) * | 2009-09-07 | 2011-11-02 | 重庆泰濠制药有限公司 | 一种盐酸伊立替康的纯化方法 |
| US8546573B2 (en) | 2009-11-18 | 2013-10-01 | Cadila Healthcare Limited | Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperdino] carbonyloxy-camptothecin hydrochloride trihydrate |
| JO3283B1 (ar) | 2011-04-26 | 2018-09-16 | Sanofi Sa | تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI) |
| CN102866126B (zh) * | 2011-07-05 | 2016-03-23 | 重庆华邦制药有限公司 | 一种定量测定化合物中晶型比例的方法 |
| CN102311443B (zh) * | 2011-08-24 | 2014-07-16 | 上海北卡医药技术有限公司 | 盐酸伊立替康的新晶型及其制备方法 |
| RU2529831C2 (ru) * | 2012-11-30 | 2014-09-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Российский университет дружбы народов" (РУДН) | Способ лечения рака толстой кишки |
| SI3170005T1 (sl) | 2014-07-18 | 2019-08-30 | Sanofi | Postopek napovedovanja izida zdravljenja z afliberceptom, pacienta, pri katerem obstaja sum, da je zbolel za rakom |
| KR102293907B1 (ko) * | 2015-06-30 | 2021-08-26 | 한미약품 주식회사 | 이리노테칸 함유 경구용 고형제제 및 그 제조방법 |
| KR102066402B1 (ko) * | 2017-12-22 | 2020-01-15 | 대화제약 주식회사 | 이리노테칸 또는 그의 약제학적으로 허용가능한 염을 포함하는 경구투여용 약제학적 조성물 |
| US10919905B2 (en) | 2019-05-16 | 2021-02-16 | Scinopharm Taiwan, Ltd. | Polymorphism for irinotecan free base |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6019790A (ja) * | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
| IT1282673B1 (it) * | 1996-02-23 | 1998-03-31 | Ist Naz Stud Cura Dei Tumori | Derivati della camptotecina e loro uso come agenti antitumorali |
| GB9918885D0 (en) * | 1999-08-10 | 1999-10-13 | Pharmacia & Upjohn Spa | Pharmaceutical formulations in hydroxypropymethycellulose capsules |
-
2003
- 2003-02-26 AU AU2003215594A patent/AU2003215594A1/en not_active Abandoned
- 2003-02-26 EP EP03743335A patent/EP1487840B1/en not_active Expired - Lifetime
- 2003-02-26 NZ NZ534999A patent/NZ534999A/en unknown
- 2003-02-26 CN CNB038072726A patent/CN1276923C/zh not_active Expired - Fee Related
- 2003-02-26 JP JP2003572995A patent/JP2005525367A/ja not_active Withdrawn
- 2003-02-26 PT PT03743335T patent/PT1487840E/pt unknown
- 2003-02-26 CA CA002477926A patent/CA2477926A1/en not_active Abandoned
- 2003-02-26 KR KR10-2004-7013621A patent/KR20040091083A/ko not_active Withdrawn
- 2003-02-26 ES ES03743335T patent/ES2287495T3/es not_active Expired - Lifetime
- 2003-02-26 MX MXPA04008484A patent/MXPA04008484A/es not_active Application Discontinuation
- 2003-02-26 AT AT03743335T patent/ATE364610T1/de not_active IP Right Cessation
- 2003-02-26 PL PL03372318A patent/PL372318A1/xx not_active Application Discontinuation
- 2003-02-26 IL IL16382003A patent/IL163820A0/xx unknown
- 2003-02-26 DK DK03743335T patent/DK1487840T3/da active
- 2003-02-26 BR BR0308133-8A patent/BR0308133A/pt not_active IP Right Cessation
- 2003-02-26 RU RU2004129307/04A patent/RU2300535C2/ru not_active IP Right Cessation
- 2003-02-26 DE DE60314378T patent/DE60314378T2/de not_active Expired - Fee Related
- 2003-02-26 WO PCT/EP2003/001948 patent/WO2003074527A1/en not_active Ceased
- 2003-02-27 TW TW092104194A patent/TWI270374B/zh not_active IP Right Cessation
- 2003-02-28 AR ARP030100656A patent/AR038618A1/es unknown
- 2003-02-28 PE PE2003000196A patent/PE20030923A1/es not_active Application Discontinuation
-
2004
- 2004-08-31 ZA ZA200406927A patent/ZA200406927B/en unknown
- 2004-09-29 NO NO20044138A patent/NO20044138L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI270374B (en) | 2007-01-11 |
| MXPA04008484A (es) | 2004-12-06 |
| ATE364610T1 (de) | 2007-07-15 |
| AU2003215594A1 (en) | 2003-09-16 |
| CN1642958A (zh) | 2005-07-20 |
| PT1487840E (pt) | 2007-09-11 |
| KR20040091083A (ko) | 2004-10-27 |
| EP1487840B1 (en) | 2007-06-13 |
| RU2300535C2 (ru) | 2007-06-10 |
| DK1487840T3 (da) | 2007-07-16 |
| RU2004129307A (ru) | 2005-04-10 |
| JP2005525367A (ja) | 2005-08-25 |
| EP1487840A1 (en) | 2004-12-22 |
| WO2003074527A1 (en) | 2003-09-12 |
| IL163820A0 (en) | 2005-12-18 |
| TW200303753A (en) | 2003-09-16 |
| HK1075044A1 (en) | 2005-12-02 |
| AR038618A1 (es) | 2005-01-19 |
| BR0308133A (pt) | 2005-01-04 |
| PL372318A1 (en) | 2005-07-11 |
| NZ534999A (en) | 2007-03-30 |
| DE60314378T2 (de) | 2008-02-28 |
| DE60314378D1 (en) | 2007-07-26 |
| CN1276923C (zh) | 2006-09-27 |
| CA2477926A1 (en) | 2003-09-12 |
| ES2287495T3 (es) | 2007-12-16 |
| ZA200406927B (en) | 2006-06-28 |
| NO20044138L (no) | 2004-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030923A1 (es) | Forma polimorfica cristalina de clorhidrato de irinotecan | |
| BRPI0409198A (pt) | derivados quinolin-2-ona para o tratamento de doenças de vias aéreas | |
| EP4616908A3 (en) | Oxysterols and methods of use thereof | |
| TN2009000180A1 (en) | NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF | |
| BRPI0720551A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, e, uso do mesmo, método para o tratamento de câncer, processos para a preparação de uma composição farmacêutica e de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
| MX2009004096A (es) | Metabolitos de talarozol. | |
| BRPI0418181A (pt) | emprego de 2-aminotetralinas substituìdas para prevenção do tratamento de morbus parkinson | |
| WO2008059370A8 (en) | Substituted bicyclocarboxyamide compounds | |
| WO2008050199A8 (en) | Substituted phenylmethyl bicyclocarboxyamide compounds | |
| TW200630374A (en) | Thiazolyldihydroindazoles | |
| WO2005115470A3 (fr) | COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE β-CARBOLINE, ET LEUR UTILISATION POUR LE TRAITEMENT DES CANCERS | |
| WO2010075280A3 (en) | Coumarin-based compounds for the treatment of alzheimer's disease and cancer | |
| IL183636A0 (en) | Quinoline derivative, use and production thereof, and drug containing the same | |
| ZA200709094B (en) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility | |
| WO2006100082A3 (de) | Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung | |
| UA94580C2 (ru) | Аналог 39-дезметоксирапамицина, способный преодолевать гематоэнцефалический барьер, для лечения патологического состояния, вызванного нейрогенным повреждением или заболеванием | |
| IL186748A0 (en) | 4 - phenyl - 5 - oxo 1, 4, 5, 6, 7, 8 - hexahydroquinoline derivatives for the treatment of infertility | |
| WO2015042414A8 (en) | Multicyclic compounds and methods of using same | |
| IL187001A0 (en) | Preparation of (s)-4-fluromethyl-dihydro-furan -2-one | |
| UY28486A1 (es) | Compuestos quimicos | |
| IL185410A0 (en) | Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of parkinson's disease | |
| WO2006050861A3 (en) | Statine derivatives for the treatment of alzheimer's disease | |
| CL2008003928A1 (es) | Compuestos derivados de n-6-heterociclo-imidazo-[1,2-a]-piridin-2-carboxamida sustituidos; procedimiento de preparacion; composicion farmaceutica; utiles en el tratamiento y/o prevencion de enfermedades neurodegenerativas, inflamatorias, epilepsia, osteoporosis, tumores malignos, entre otras. | |
| MX2009005242A (es) | Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo. | |
| SI1879581T1 (sl) | 4-fenil-5-okso-1,4,5,6,7,8-heksahidrokinolinski derivati kot zdravila za zdravljenje neplodnosti |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |